William A. Wood

TL;DR: The outcomes of a cohort of patients with cancer and COVID-19 are characterised and potential prognostic factors for mortality and severe illness are identified and race and ethnicity, obesity status, cancer type, type of anticancer therapy, and recent surgery were not associated with mortality.

TL;DR: Adult patients with hematologic malignancy and COVID-19, especially hospitalized patients, have a high risk of dying and adults aged ≥60 years have significantly higher mortality; pediatric patients appear to be relatively spared.

TL;DR: Current outcomes of unrelated donor allogeneic hematopoietic cell transplantation (HCT) is examined to determine the clinical implications of donor-recipient HLA matching, and full matching at HLA-A, -B, -C, and -DRB1 is required for optimal unrelated donor HCT survival.

TL;DR: The intent is to clarify core terminology and best practices for the evaluation of Biometric Monitoring Technologies (BioMeTs), without unnecessarily introducing new terms, and aim for this common vocabulary to enable more effective communication and collaboration, generate a common and meaningful evidence base for BioMeTs, and improve the accessibility of the digital medicine field.

TL;DR: Over the past decade, utilization and survival after allogeneic transplant have increased in patients ≥70 years with hematologic malignancies across the United States.